Advance your cell, gene and immunotherapies towards commercial success

by Alexey Bersenev on July 31, 2015 · 0 comments

in conferences

Post to Twitter Send Gmail Post to LinkedIn

This is promotional post by Howard Choi

Learn to how to apply the cost-effective and efficient strategies you need to advance your cell, gene and immunotherapies towards commercial success by attending IBC’s Cell Therapy Bioprocessing & Commercialization meeting, held September 30 – October 2, 2015 in Alexandria, VA.

For full program details, download the brochure today at

Translation of Regenerative Medicine
Julie G. Allickson, Ph.D., Wake Forest Institute for Regenerative Medicine

Building our Biological Future
Rob Carlson BioEconomy Capital

Overcoming Challenges for Engineered Autologous T Cell Therapy
Marc Better, Ph.D. Kite Pharma

CAR Therapy: The CD19 Paradigm and Beyond
Michel Sadelain, Memorial Sloan Kettering Cancer Center

Secure your seat today to attend this year’s meeting and learn alongside fellow developers and end-users as you collectively share ideas, solutions and lessons learned to:

  • Accelerate your path from concept to product by applying insightful and relevant strategies from 80+ industry thought-leading speakers across 7 focused tracks
  • Stay at the forefront of innovation by evaluating new technologies and cutting-edge data in the exhibit and poster hall
  • Jump start collaborations and partnerships through networking luncheons, private exhibit hall tours, evening cocktail receptions, interactive panel discussions and more

Register online at with code B15188SCA to receive a 20% registration discount off the standard rate (new registrations only).

For general questions about the meeting, contact Howie Choi at

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: